In stark contrast, Adipotide utilizes a mechanism of vascular targeting to induce apoptosis (programmed cell death) in the blood vessels supplying fat cells, causing the tissue to degrade via hypoxia
When the FDA added a number of injectable peptides to its list of restricted substances in 2023, it cited safety risks including cancer and liver, kidney and heart problems
These work together to make tissue repair more effective than many other peptides on the market
However, safety depends on several factors: injection site rotation to avoid lipodystrophy, adequate hydration (both agents can increase fluid demand), and monitoring of B vitamin status since semaglutide may affect nutrient absorption slightly during rapid weight loss phases
This is fundamentally different from immune suppression, which simply reduces all immune activity regardless of its target
doi: 10.3389/fnut.2021.761267 163